During the past decade, KYS Sadesairaala; Syopatautien poliklinikka conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "KYS Sadesairaala; Syopatautien poliklinikka" are "Breast Cancer" (2 trials), "HER2-Positive Early Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "KYS Sadesairaala; Syopatautien poliklinikka" in a lesser frequency.

Most popular intervention types in "KYS Sadesairaala; Syopatautien poliklinikka" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Fulvestrant" (1 trials), "Ipatasertib" (1 trials), "Paclitaxel" (1 trials) and "Pertuzumab IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "KYS Sadesairaala; Syopatautien poliklinikka" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KYS Sadesairaala; Syopatautien poliklinikka". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in KYS Sadesairaala; Syopatautien poliklinikka, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in KYS Sadesairaala; Syopatautien poliklinikka, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".